Managing childhood obesity: When lifestyle change is not enough

Diabetes, Obesity and Metabolism

Volumn 12, Issue 11, 2010, Pages 947-957

  Hearnshaw, C ^a   Matyka, K ^b  

^a BIRMINGHAM CHILDREN S HOSPITAL NHS FOUNDATION TRUST   (United Kingdom)

^b UNIVERSITY OF WARWICK   (United Kingdom)

Author keywords

Adolescent; Bariatric surgery; Obesity therapy; Pharmacotherapy

Indexed keywords

METFORMIN; PLACEBO; SIBUTRAMINE; TETRAHYDROLIPSTATIN;

ADOLESCENT DISEASE; BARIATRIC SURGERY; BEHAVIOR THERAPY; BODY MASS; CHILDHOOD DISEASE; CLINICAL TRIAL; DRUG DOSE INCREASE; DRUG WITHDRAWAL; GASTROINTESTINAL DISEASE; HUMAN; HYPERTENSION; LIFESTYLE MODIFICATION; MEDICAL LITERATURE; MEDLINE; META ANALYSIS; OBESITY; REVIEW; SYSTEMATIC REVIEW; TREATMENT DURATION;

EID: 77957311957     PISSN: 14628902     EISSN: 14631326     Source Type: Journal    
DOI: 10.1111/j.1463-1326.2010.01286.x     Document Type: Review

References (51)

1. Lobstein T, Baur L, Uauy R. Obesity in children and young people: a crisis in public health. Obes Rev 2004, 5(Suppl. 1):4-85.. IASO International Obesity TaskForce.
2. Oude Luttikhuis H, Baur L, Jansen H. Interventions for treating obesity in children. Cochrane Database Syst Rev 2009, 1. CD001872.
3. Arslanian SA, Lewy V, Danadian K, Saad R. Metformin therapy in obese adolescents with polycystic ovary syndrome and impaired glucose tolerance: amelioration of exaggerated adrenal response to adrenocorticotropin with reduction of insulinemia/insulin resistance. J Clin Endocrinol Metab 2002, 87:1555-1559..
4. Kay JP, Alemzadeh R, Langley G, D'Angelo L, Smith P, Holshouser S. Beneficial effects of metformin in normoglycemic morbidly obese adolescents. Metab Clin Exp 2001, 50:1457-1461..
5. Freemark M, Bursey D. The effects of metformin on body mass index and glucose tolerance in obese adolescents with fasting hyperinsulinemia and a family history of type 2 diabetes. Pediatrics 2001, 107:e55..
6. Fu JF, Liang L, Zou CC. Prevalence of the metabolic syndrome in Zhejiang Chinese obese children and adolescents and the effect of metformin combined with lifestyle intervention. Int J Obes 2007, 31:15-22..
7. Srinivasan S, Ambler GR, Baur LA. Randomized, controlled trial of metformin for obesity and insulin resistance in children and adolescents: improvement in body composition and fasting insulin. J Clin Endocrinol Metab 2006, 91:2074-2080..
8. Clarson CL, Mahmud FH, Baker JE. Metformin in combination with structured lifestyle intervention improved body mass index in obese adolescents, but did not improve insulin resistance. Endocrine 2009, 36:141-146..
9. Hoeger K, Davidson K, Kochman L, Cherry T, Kopin L, Guzick DS. The impact of metformin, oral contraceptives, and lifestyle modification on polycystic ovary syndrome in obese adolescent women in two randomized, placebo-controlled clinical trials. J Clin Endocrinol Metab 2008, 93:4299-4306..
10. Krzystek-Korpacka M, Patryn E, Boehm D, Berdowska I, Zielinski B, Noczynska A. Advanced oxidation protein products (AOPPs) in juvenile overweight and obesity prior to and following weight reduction. Clin Biochem 2008, 41:943-949..
11. Atabek ME, Pirgon O. Use of metformin in obese adolescents with hyperinsulinemia: a 6-month, randomized, double-blind, placebo-controlled clinical trial. J Pediatr Endocrinol 2008, 21:339-348..
12. Love-Osborne K, Sheeder J, Zeitler P. Addition of metformin to a lifestyle modification program in adolescents with insulin resistance. J Pediatr 2008, 152:817-822..
13. Freemark M. Liver dysfunction in paediatric obesity: a randomized, controlled trial of metformin. Acta Paediatr 2007, 96:1326-1332..
14. Violante-Ortiz R, Del-Rio-Navarro BE, Lara-Esqueda A. Use of sibutramine in obese Hispanic adolescents. Adv Ther 2005, 22:642-649..
15. Godoy-Matos A, Carraro L, Vieira A. Treatment of obese adolescents with sibutramine: a randomized, double-blind, controlled study. J Clin Endocrinol Metab 2005, 90:1460-1465..
16. Garcia-Morales LM, Berber A, Macias-Lara CC, Lucio-Ortiz C, Del-Rio-Navarro BE, Dorantes-Alvarez LM. Use of sibutramine in obese mexican adolescents: a 6-month, randomized, double-blind, placebo-controlled, parallel-group trial. Clin Ther 2006, 28:770-782..
17. Berkowitz RI, Fujioka K, Daniels SR. Sibutramine Adolescent Study Group. Effects of sibutramine treatment in obese adolescents: a randomized trial. Ann Intern Med 2006, 145:81-90..
18. Daniels SR, Long B, Crow S. Cardiovascular effects of sibutramine in the treatment of obese adolescents: results of a randomized, double-blind, placebo-controlled study. Pediatrics 2007, 120:e147-e157..
19. Budd GM, Hayman LL, Crump E. Weight loss in obese African American and Caucasian adolescents: secondary analysis of a randomized clinical trial of behavioral therapy plus sibutramine. J Cardiovasc Nurs 2007, 22:288-296..
20. Van Mil EG, Westerterp KR, Kester AD, Delemarre-van de Waal HA, Gerver WJ, Saris WH. The effect of sibutramine on energy expenditure and body composition in obese adolescents. J Clin Endocrinol Metab 2007, 92:1409-1414..
21. Chanoine JP, Hampl S, Jensen C, Boldrin M, Hauptman J. Effect of orlistat on weight and body composition in obese adolescents: a randomized controlled trial. JAMA 2005, 293:2873-2883..
22. Maahs D, de Serna DG, Kolotkin RL. Randomized, double-blind, placebo-controlled trial of orlistat for weight loss in adolescents. Endocr Pract 2006, 12:18-28..
23. Nadler EP, Youn HA, Ren CJ, Fielding GA. An update on 73 US obese pediatric patients treated with laparoscopic adjustable gastric banding: comorbidity resolution and compliance data. J Pediatr Surg 2008, 43:14..
24. Strauss RS, Bradley LJ, Brolin RE. Gastric bypass surgery in adolescents with morbid obesity. J Pediatr 2001, 38:499-504..
25. Capella JF, Capella RF. Bariatric surgery in adolescence. Is this the best age to operate? Obes Surg 2003, 13:826-832..
26. Sugerman HJ, Sugerman EL, DeMaria EJ. Bariatric surgery for severely obese adolescents. J Gastrointest Surg 2003, 7:102-107..
27. Barnett SJ, Stanley C, Hanlon M. Long-term follow-up and the role of surgery in adolescents with morbid obesity. Surg Obes Relat Dis 2005, 1:394-398..
28. Kalra M, Inge T, Garcia V. Obstructive sleep apnea in extremely overweight adolescents undergoing bariatric surgery. Obes Res 2005, 13:1175-1179..
29. Lawson ML, Kirk S, Mitchell T. One-year outcomes of Roux-en-Y gastric bypass for morbidly obese adolescents: a multicenter study from the Pediatric Bariatric Study Group. J Pediatr Surg 2006, 41:137-143..
30. Collins J, Mattar S, Qureshi F. Initial outcomes of laparoscopic Roux-en-Y gastric bypass in morbidly obese adolescents. Surg Obes Relat Dis 2007, 3:147-152..
31. Dillard BE, Gorodner V, Galvani C. Initial experience with the adjustable gastric band in morbidly obese US adolescents and recommendations for further investigation. J Pediatr Gastroenterol Nutr 2007, 45:240-246..
32. Holterman A-X, Browne A, Dillard BE. Short-term outcome in the first 10 morbidly obese adolescent patients in the FDA-approved trial for laparoscopic adjustable gastric banding. J Pediatr Gastroenterol Nutr 2007, 45:465-473..
33. Inge T, Wilson KA, Gamm K, Kirk S, Garcia VF, Daniels SR. Preferential loss of central (trunk) adiposity in adolescents and young adults after laparoscopic gastric bypass. Surg Obes Relat Dis 2007, 3:153-158..
34. Ippisch HM, Inge TH, Daniels SR. Reversibility of cardiac abnormalities in morbidly obese adolescents. J Am Coll Cardiol 2008, 51:1342-1348..
35. Loux TJ, Haricharan RN, Clements RH. Health-related quality of life before and after bariatric surgery in adolescents. J Pediatr Surg 2008, 43:1275-1279..
36. Zeller MH, Modi AC, Noll JG, Long JD, Inge TH. Psychosocial functioning improves following adolescent bariatric surgery. Obesity 2009, 17:985-990..
37. Nadler EP, Reddy S, Isenalumhe A. Laparoscopic adjustable gastric banding for morbidly obese adolescents affects android fat loss, resolution of comorbidities, and improved metabolic status. J Am Coll Surg 2009, 209:638-644..
38. Abu-Abeid S, Gavert N, Klausner JM, Szold A. Bariatric surgery in adolescence. J Pediatr Surg 2003, 38:1379-1382..
39. Al-Qahtani AR. Laparoscopic adjustable gastric banding in adolescent: safety and efficacy. J Pediatr Surg 2007, 42:894-897..
40. Fielding GA, Duncombe JE. Laparoscopic adjustable gastric banding in severely obese adolescents. Surg Obes Relat Dis 2005, 1:399-405..
41. Angrisani L, Favretti F, Furbetta F. Obese teenagers treated by Lap-Band System: the Italian experience. Surgery 2005, 138:877-881..
42. Papadia FS, Adami GF, Marinari GM, Camerini G, Scopinaro N. Bariatric surgery in adolescents: a long-term follow-up study. Surg Obes Relat Dis 2007, 3:465-468..
43. Silberhumer GR, Miller K, Kriwanek S, Widhalm K, Pump A, Prager G. Laparoscopic adjustable gastric banding in adolescents: the Austrian experience. Obes Surg 2006, 16:1062-1067..
44. NIH conference. Gastrointestinal surgery for severe obesity. Consensus Development Conference Panel. Ann Int Med 1991, 115:956-961..
45. Obesity, guidance on the prevention, identification, assessment and management of overweight and obesity in adults and children. NICE Clinical Guideline 43. 2006, National Institute for Health and Clinical Excellence., London, NICE
46. Weiss R, Taksali SE, Tamborlane WV, Burgert TS, Savoye M, Caprio S. Predictors of changes in glucose tolerance status in obese youth. Diabetes care 2005, 28:902-909..
47. Goodman E, Daniels SR, Meigs JB, Dolan LM. Instability in the diagnosis of metabolic syndrome in adolescents. Circulation 2007, 115:2316-2322..
48. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002, 346:393-403.. The Diabetes Prevention Program Research Group.
49. Pinhas-Hamiel O, Zeitler P. Acute and chronic complications of type 2 diabetes mellitus in children and adolescents. Lancet 2007, 369:1823-1831..
50. Tsai WS, Inge TH, Burd RS. Bariatric surgery in adolescents. Arch Pediatr Adolesc Med 2007, 161:217-221..
51. Buchwald H, Avidor Y, Braunwald E. Bariatric surgery: a systematic review and meta-analysis. JAMA 2004, 292:1724-1737..